Concomitant administration of brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup and MAO inhibitors should be avoided (see CONTRAINDICATIONS).
Source: FDA drug label - brompheniramine maleate, pseudoephedrine hydrochloride,